Therapeutic effects of lenvatinib in combination with rAd-p53 for the treatment of non-small cell lung cancer

about

Therapeutic effects of lenvatinib in combination with rAd-p53 for the treatment of non-small cell lung cancer

Item

http://www.wikidata.org/entity/Q58572423

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Therapeutic effects of lenvati ...... of non-small cell lung cancer

@en

Therapeutic effects of lenvati ...... of non-small cell lung cancer

@nl

type

Item

label

Therapeutic effects of lenvati ...... of non-small cell lung cancer

@en

Therapeutic effects of lenvati ...... of non-small cell lung cancer

@nl

prefLabel

Therapeutic effects of lenvati ...... of non-small cell lung cancer

@en

Therapeutic effects of lenvati ...... of non-small cell lung cancer

@nl

P1476

Therapeutic effects of lenvati ...... of non-small cell lung cancer

@en

P2093

Aiying Jiang

http://www.w3.org/2001/XMLSchema#string

Huixin Yao

http://www.w3.org/2001/XMLSchema#string

Minghuan Wang

http://www.w3.org/2001/XMLSchema#string

Renzhi Yu

http://www.w3.org/2001/XMLSchema#string

Xiuli Zhu

http://www.w3.org/2001/XMLSchema#string

Zhe Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer.

Ectodomain shedding of HB-EGF: a potential target for cancer therapy.

Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models

Selective intra-arterial infusion of rAd-p53 with chemotherapy for advanced oral cancer: a randomized clinical trial.

Lipoprotein lipase as a candidate target for cancer prevention/therapy

ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene.

Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies

Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing.

Utility of Routine PET Imaging to Predict Response and Survival After Induction Therapy for Non-Small Cell Lung Cancer.

P304

6573-6581

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.9428

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30405797

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6202525

http://www.w3.org/2001/XMLSchema#string